Clinical Trial Update: Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of fenofibrate on endothelial function and HDL in patients with coronary heart disease and hyperlipidemia has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Hyperlipidemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: National Heart Institute, Mexico | Conditions: Coronary Heart Disease, Hyperlipidemia | Phase 4 | Status: COMPLETED